Clinical Trials for Recurrent Fallopian Tube Carcinoma

Find clinical trials for recurrent fallopian tube carcinoma. Discover research opportunities and treatment options in your area.

13 Active Trials Found

Showing 13 trials on this page

Page 1 of 1

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

NCT ID: NCT05564377

The ComboMATCH Screening Trial is a study that aims to find effective treatments for patients with advanced solid tumors, such as certain types of breast cancer and other cancers that have spread e...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States, Durham, North Carolina, United States +492 more

Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

NCT ID: NCT05554328

This clinical trial, called the ComboMATCH treatment trial, is studying a new way to treat certain types of ovarian and endometrial cancers. Specifically, the trial is comparing two treatments: one...

Recruiting

Phase: PHASE2 Type: interventional Locations: Durham, North Carolina, United States, Cleveland, Ohio, United States +301 more

Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer

NCT ID: NCT04469764

This clinical trial is studying a medication called abemaciclib to see how well it works for women with recurrent ovarian or endometrial cancer. These are types of cancer that can come back after t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Los Angeles, California, United States

Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

NCT ID: NCT05920798

This clinical trial is studying a new treatment approach for women with advanced ovarian, fallopian tube, or primary peritoneal cancer. Researchers want to see how well a combination of a special t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Scottsdale, Arizona, United States, Jacksonville, Florida, United States +1 more

ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer

NCT ID: NCT04055649

This clinical trial is studying a combination of two treatments, ONC201 and paclitaxel, to see how effective they are for women with certain types of ovarian cancer that have not responded well to ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Detroit, Michigan, United States, Flint, Michigan, United States

Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers

NCT ID: NCT05691504

This clinical trial is investigating the use of two medications, APG-1252 (also known as Pelcitoclax) and Cobimetinib, to see if they can safely treat patients with advanced or recurrent ovarian an...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bethesda, Maryland, United States, Boston, Massachusetts, United States +5 more

An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study

NCT ID: NCT06855706

The "Life on the Go 3 Study" is a clinical trial designed to see how a personalized physical activity program, supported by wearable technology, can help improve the health and quality of life for ...

Recruiting

Phase: NA Type: interventional Locations: Buffalo, New York, United States

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

NCT ID: NCT05231122

This clinical trial is studying a new treatment approach for women with recurrent ovarian cancer, specifically looking at how well pembrolizumab and bevacizumab work together, with or without an ad...

Recruiting

Phase: PHASE2 Type: interventional Locations: Buffalo, New York, United States, Houston, Texas, United States

APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion

NCT ID: NCT04919629

This clinical trial is studying new treatment options for women with recurrent ovarian, fallopian tube, or primary peritoneal cancer, particularly in cases where there is a buildup of fluid and can...

Recruiting

Phase: PHASE2 Type: interventional Locations: Buffalo, New York, United States

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

NCT ID: NCT03604315

This clinical trial is testing a new imaging technique using a special radioactive agent called Fluorine F 18 fluorthanatrace, or [^18F] FTT, to help doctors see solid tumors more clearly in women ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

NCT ID: NCT03968406

This clinical trial is studying a new treatment approach for women with certain types of gynecologic cancers that have come back after previous therapies. Specifically, it looks at combining a medi...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Baltimore, Maryland, United States

Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study

NCT ID: NCT06295965

The CHANCES Study is a research trial looking at how certain changes in blood cells, known as clonal hematopoiesis, may affect women who have survived ovarian cancer. The goal is to understand if t...

Recruiting

Type: observational Locations: Seattle, Washington, United States

MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer

NCT ID: NCT06483048

This clinical trial is studying a new treatment approach for women with certain types of ovarian cancer that have returned after treatment or did not respond to previous therapies. The treatment in...

Recruiting

Phase: PHASE1 Type: interventional Locations: Scottsdale, Arizona, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions